Biosign Technologies (BITKF) 0.0200 $BITKF
Biosign completes sale of hardware division and unwinds investment in Higher Bracket Online Media Inc.
CNW Group - Wed Sep 17, 4:25PM CDT
Biosign Technologies Inc. (TSXV: BIO) ("Biosign" or the "Company"
announces that it has completed the sale of its hardware division to Cloud DX Inc. ("Cloud DX" . On August 11, 2014, Biosign announced it had reached an agreement in principle to sell certain assets related to the Company's Pulsewave medical device product line ("the Agreement" with Vancouver-based Global Life Safety Group Inc. ("Global" . Cloud DX, a New York-based affiliate of Global, acquired the Pulsewave assets, intellectual property and certain other intangible assets, for a total purchase price of $2,000,000 to be paid over 5 years with minimum payments of $100,000 per year. Biosign was paid $25,000 on closing and an additional $80,000 is expected to be received from Cloud DX on or before October 15, 2014. Payments will be accelerated upon satisfaction of certain financing and other milestones achieved by Cloud DX. In addition, Cloud DX has assumed the operating costs of the Pulsewave division, including various real estate, physical plant, human capital, R&D and manufacturing expenses. As part of this transaction, Biosign has been granted distribution rights from Cloud DX as well as the ability to integrate Pulsewave and future related products with Biosign solutions.
Biosign sells 12.5% of MECK Medical GmbH to raise additional funds
CNW Group - Thu Aug 28, 5:56PM CDT
Biosign Technologies Inc. (TSXV: BIO) ("Biosign" or the "Company" announced the completion of a Share Purchase Agreement (the "SPA" with 3282909 Nova Scotia Limited ("the Investor" under which it has sold 12.5% of its 51% ownership stake of the issued and outstanding shares of MECK Medical GmbH ("MECK" previously acquired on June 30, 2014. The Investor who paid $400,000 on closing for the stake in MECK is a corporation owned by Dr. Michael Gross who is Chairman and acting CEO of Biosign. The Investor has committed to pay an additional $75,000 subsequent to closing.
Biosign Agrees to Sell its Hardware Division; Resignation of CEO and Director; Appointment of New CEO
CNW Group - Mon Aug 11, 8:00AM CDT
Biosign Technologies Inc. (TSXV: BIO) ("Biosign" or the "Company" announced it has reached an agreement in principle with Vancouver-based Global Life Safety Group Inc. ("Global) to divest certain assets related to the Company's Pulsewave® medical device product line. Following completion of such transaction, the Company intends to focus on delivering healthcare IT solutions through the faster-growing software divisions of the Company, including particularly AioMed GmbH in Germany.
Biosign Adds Ron Kelusky to the Board of Directors
CNW Group - Thu Jul 24, 3:01PM CDT
Biosign Technologies Inc. (TSXV: BIO) ("Biosign" or the "Company" is pleased to announce the appointment of Ron Kelusky to the Board. Mr. Kelusky is the President & CEO of Public Services Health & Safety Association of Ontario (PSHSA). PSHSA works with Ontario's 10,000 public and broader public service sector employers and 1.5 million workers, offering consulting, training, resources, plus health & safety products and information to clients in health and community care, education and culture, municipal and provincial government, and public safety and First Nations communities. From 2009-2013 Mr Kelusky was Director General of the Canadian Red Cross, responsible for Ontario operations and all National Health programming, overseeing 4,000 full and part time staff, 6,000 volunteers and an annual operating budget of $175.0 million. From 2006 - 2009 he was President, Health Division for GestureTek Incorporated; from 2003-2006 he was Chief Operating Officer for March of Dimes Canada; and from 1998-2003 he served as Chief and General Manager for the City of Toronto Emergency Medical Services. Mr. Kelusky has an MBA from Athabasca University.
Biosign Closes Acquisition of 51% of Meck Medical GmbH, secures demand loan and seeks further financing
CNW Group - Fri Jul 04, 5:23PM CDT
Biosign Technologies Inc. (TSXV: BIO) (the "Company" is pleased to announce that it has completed the previously-announced acquisition of 51% of issued and outstanding shares of Meck Medical GmbH ("MECK" . Klingenberg Germany-based MECK is a developer of innovative healthcare software solutions assembled into a cloud-based platform that provides facility management services, document management, prescription management, wound management and social networking services to the long term care, nursing home and extended care industries in Germany.
Biosign Technologies Inc. - Resignation of Board Director
CNW Group - Wed Jul 02, 5:03PM CDT
Biosign Technologies Inc. (TSXV: BIO) ("Biosign" or the "Company" announced that Mr. John-Peter Bradford has resigned from the Board, effective June 27th, 2014.
Biosign Acquires 51% of Meck Medical GmbH
CNW Group - Thu Jun 19, 4:05PM CDT
/Not for distribution in the United States or through United States wire services/
Biosign positions itself for growth: Strengthens the Board, secures debt financing & looks to acquire additional software assets
CNW Group - Tue Mar 25, 1:05PM CDT
/NOT FOR DISTRIBUTION IN THE UNITED STATES OR THROUGH UNITED STATES WIRE SERVICES/
Biosign enjoys success at Arab Health 2014
CNW Group - Thu Feb 06, 8:00AM CST
/NOT FOR DISTRIBUTION IN THE UNITED STATES OR THROUGH UNITED STATES WIRE SERVICES/
Biosign supports Heart & Stroke Foundation during Heart Month
CNW Group - Wed Feb 05, 8:25AM CST
/NOT FOR DISTRIBUTION IN THE UNITED STATES OR THROUGH UNITED STATES WIRE SERVICES/
Biosign acquires 100% of QLINE Solutions Inc.
CNW Group - Wed Jan 08, 3:01PM CST
/NOT FOR DISTRIBUTION IN THE UNITED STATES OR THROUGH UNITED STATES WIRE SERVICES/
Biosign to Showcase Star Trek-like Health Monitor at Medica Debut
PRWeb - Wed Aug 14, 7:11AM CDT
Biosign Technologies Inc. (TSXV: BIO) ("Biosign" or the "Company" will bring two major innovations in patient monitoring when the Company exhibits for the first time at MEDICA, the globe's largest annual medical trade fair. Regarded as the world stage for medical invention, MEDICA 2013 in Dusseldorf Germany, November 20-23 will attract over 4,000 exhibitors from more than 60 countries.
Biosign Adds New Board Director
CNW Group - Thu Aug 08, 12:28PM CDT
Biosign Technologies Inc. (TSXV: BIO) ("Biosign" or the "Company" is pleased to announced the appointment of Dr. Michael Gross to the Company's Board of Directors.
Biosign announces $180,000 clinical validation study
CNW Group - Thu Jul 25, 9:02AM CDT
Biosign Technologies Inc. (TSXV: BIO) ("Biosign" or the "Company" announced the completion of a Memorandum of Understanding with Health + Life Science New Brunswick Inc. ("HLSNB" to participate in the "Biosign Critical Care Validation Project" ("CCV Project" , an equal-stake private-public co-operative project between Biosign, HLSNB, the New Brunswick Health Research Foundation ("NBHRF" and the University of New Brunswick, Saint John ("UNB" (together, "CCV Project partners" .
Biosign begins television advertising
CNW Group - Fri Jul 12, 3:05PM CDT
Biosign Technologies Inc. (TSXV: BIO) ("Biosign" or the "Company" announces the following:
Biosign enters into LOI with QLINE Solutions
CNW Group - Thu Jul 11, 8:00AM CDT
/NOT FOR DISTRIBUTION IN THE UNITED STATES OR THROUGH UNITED STATES WIRE SERVICES./
Biosign Investor Conference Call scheduled
CNW Group - Fri Jul 05, 2:08PM CDT
Biosign Technologies Inc. (TSXV: BIO) ("Biosign" or the "Company" made the following announcements:
Biosign Begins Sales Effort In the United States
ACCESSWIRE - Mon Jun 24, 4:12PM CDT
TORONTO, ONTARIO, June 24th, 2013 - Biosign Technologies Inc. (TSXV: BIO) ("Biosign" or the "Company" made the following statement:
Biosign investor update
CNW Group - Wed May 29, 7:30AM CDT
Biosign Technologies Inc. (TSXV: BIO) ("Biosign" or the "Company" announced:
Biosign completes sale of hardware division and unwinds investment in Higher Bracket Online Media Inc.
CNW Group - Wed Sep 17, 4:25PM CDT
Biosign Technologies Inc. (TSXV: BIO) ("Biosign" or the "Company"
announces that it has completed the sale of its hardware division to Cloud DX Inc. ("Cloud DX" . On August 11, 2014, Biosign announced it had reached an agreement in principle to sell certain assets related to the Company's Pulsewave medical device product line ("the Agreement" with Vancouver-based Global Life Safety Group Inc. ("Global" . Cloud DX, a New York-based affiliate of Global, acquired the Pulsewave assets, intellectual property and certain other intangible assets, for a total purchase price of $2,000,000 to be paid over 5 years with minimum payments of $100,000 per year. Biosign was paid $25,000 on closing and an additional $80,000 is expected to be received from Cloud DX on or before October 15, 2014. Payments will be accelerated upon satisfaction of certain financing and other milestones achieved by Cloud DX. In addition, Cloud DX has assumed the operating costs of the Pulsewave division, including various real estate, physical plant, human capital, R&D and manufacturing expenses. As part of this transaction, Biosign has been granted distribution rights from Cloud DX as well as the ability to integrate Pulsewave and future related products with Biosign solutions. Biosign sells 12.5% of MECK Medical GmbH to raise additional funds
CNW Group - Thu Aug 28, 5:56PM CDT
Biosign Technologies Inc. (TSXV: BIO) ("Biosign" or the "Company"
announced the completion of a Share Purchase Agreement (the "SPA" with 3282909 Nova Scotia Limited ("the Investor" under which it has sold 12.5% of its 51% ownership stake of the issued and outstanding shares of MECK Medical GmbH ("MECK" previously acquired on June 30, 2014. The Investor who paid $400,000 on closing for the stake in MECK is a corporation owned by Dr. Michael Gross who is Chairman and acting CEO of Biosign. The Investor has committed to pay an additional $75,000 subsequent to closing. Biosign Agrees to Sell its Hardware Division; Resignation of CEO and Director; Appointment of New CEO
CNW Group - Mon Aug 11, 8:00AM CDT
Biosign Technologies Inc. (TSXV: BIO) ("Biosign" or the "Company"
announced it has reached an agreement in principle with Vancouver-based Global Life Safety Group Inc. ("Global) to divest certain assets related to the Company's Pulsewave® medical device product line. Following completion of such transaction, the Company intends to focus on delivering healthcare IT solutions through the faster-growing software divisions of the Company, including particularly AioMed GmbH in Germany. Biosign Adds Ron Kelusky to the Board of Directors
CNW Group - Thu Jul 24, 3:01PM CDT
Biosign Technologies Inc. (TSXV: BIO) ("Biosign" or the "Company"
is pleased to announce the appointment of Ron Kelusky to the Board. Mr. Kelusky is the President & CEO of Public Services Health & Safety Association of Ontario (PSHSA). PSHSA works with Ontario's 10,000 public and broader public service sector employers and 1.5 million workers, offering consulting, training, resources, plus health & safety products and information to clients in health and community care, education and culture, municipal and provincial government, and public safety and First Nations communities. From 2009-2013 Mr Kelusky was Director General of the Canadian Red Cross, responsible for Ontario operations and all National Health programming, overseeing 4,000 full and part time staff, 6,000 volunteers and an annual operating budget of $175.0 million. From 2006 - 2009 he was President, Health Division for GestureTek Incorporated; from 2003-2006 he was Chief Operating Officer for March of Dimes Canada; and from 1998-2003 he served as Chief and General Manager for the City of Toronto Emergency Medical Services. Mr. Kelusky has an MBA from Athabasca University. Biosign Closes Acquisition of 51% of Meck Medical GmbH, secures demand loan and seeks further financing
CNW Group - Fri Jul 04, 5:23PM CDT
Biosign Technologies Inc. (TSXV: BIO) (the "Company"
is pleased to announce that it has completed the previously-announced acquisition of 51% of issued and outstanding shares of Meck Medical GmbH ("MECK" . Klingenberg Germany-based MECK is a developer of innovative healthcare software solutions assembled into a cloud-based platform that provides facility management services, document management, prescription management, wound management and social networking services to the long term care, nursing home and extended care industries in Germany. Biosign Technologies Inc. - Resignation of Board Director
CNW Group - Wed Jul 02, 5:03PM CDT
Biosign Technologies Inc. (TSXV: BIO) ("Biosign" or the "Company"
announced that Mr. John-Peter Bradford has resigned from the Board, effective June 27th, 2014. Biosign Acquires 51% of Meck Medical GmbH
CNW Group - Thu Jun 19, 4:05PM CDT
/Not for distribution in the United States or through United States wire services/
Biosign positions itself for growth: Strengthens the Board, secures debt financing & looks to acquire additional software assets
CNW Group - Tue Mar 25, 1:05PM CDT
/NOT FOR DISTRIBUTION IN THE UNITED STATES OR THROUGH UNITED STATES WIRE SERVICES/
Biosign enjoys success at Arab Health 2014
CNW Group - Thu Feb 06, 8:00AM CST
/NOT FOR DISTRIBUTION IN THE UNITED STATES OR THROUGH UNITED STATES WIRE SERVICES/
Biosign supports Heart & Stroke Foundation during Heart Month
CNW Group - Wed Feb 05, 8:25AM CST
/NOT FOR DISTRIBUTION IN THE UNITED STATES OR THROUGH UNITED STATES WIRE SERVICES/
Biosign acquires 100% of QLINE Solutions Inc.
CNW Group - Wed Jan 08, 3:01PM CST
/NOT FOR DISTRIBUTION IN THE UNITED STATES OR THROUGH UNITED STATES WIRE SERVICES/
Biosign to Showcase Star Trek-like Health Monitor at Medica Debut
PRWeb - Wed Aug 14, 7:11AM CDT
Biosign Technologies Inc. (TSXV: BIO) ("Biosign" or the "Company"
will bring two major innovations in patient monitoring when the Company exhibits for the first time at MEDICA, the globe's largest annual medical trade fair. Regarded as the world stage for medical invention, MEDICA 2013 in Dusseldorf Germany, November 20-23 will attract over 4,000 exhibitors from more than 60 countries. Biosign Adds New Board Director
CNW Group - Thu Aug 08, 12:28PM CDT
Biosign Technologies Inc. (TSXV: BIO) ("Biosign" or the "Company"
is pleased to announced the appointment of Dr. Michael Gross to the Company's Board of Directors. Biosign announces $180,000 clinical validation study
CNW Group - Thu Jul 25, 9:02AM CDT
Biosign Technologies Inc. (TSXV: BIO) ("Biosign" or the "Company"
announced the completion of a Memorandum of Understanding with Health + Life Science New Brunswick Inc. ("HLSNB" to participate in the "Biosign Critical Care Validation Project" ("CCV Project" , an equal-stake private-public co-operative project between Biosign, HLSNB, the New Brunswick Health Research Foundation ("NBHRF" and the University of New Brunswick, Saint John ("UNB" (together, "CCV Project partners" . Biosign begins television advertising
CNW Group - Fri Jul 12, 3:05PM CDT
Biosign Technologies Inc. (TSXV: BIO) ("Biosign" or the "Company"
announces the following: Biosign enters into LOI with QLINE Solutions
CNW Group - Thu Jul 11, 8:00AM CDT
/NOT FOR DISTRIBUTION IN THE UNITED STATES OR THROUGH UNITED STATES WIRE SERVICES./
Biosign Investor Conference Call scheduled
CNW Group - Fri Jul 05, 2:08PM CDT
Biosign Technologies Inc. (TSXV: BIO) ("Biosign" or the "Company"
made the following announcements: Biosign Begins Sales Effort In the United States
ACCESSWIRE - Mon Jun 24, 4:12PM CDT
TORONTO, ONTARIO, June 24th, 2013 - Biosign Technologies Inc. (TSXV: BIO) ("Biosign" or the "Company"
made the following statement: Biosign investor update
CNW Group - Wed May 29, 7:30AM CDT
Biosign Technologies Inc. (TSXV: BIO) ("Biosign" or the "Company"
announced: 
